Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Beltrand

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
European Journal of Endocrinology|March 19, 2010
Resistance to leptin-replacement therapy in Berardinelli-Seip congenital lipodystrophy: an immunological originJacques Beltrand, Najiba Lahlou, Tifenn Le Charpentier, et al.
Hormone Research in Paediatrics|January 13, 2017
Efficacy and Safety of Continuous Subcutaneous Infusion of Recombinant Human Gonadotropins for Congenital Micropenis during Early Infancy
Athanasia Stoupa, Dinane Samara-Boustani, Isabelle Flechtner, et al.
Hormone Research in Paediatrics|February 14, 2015
Inadequate cortisol response to the tetracosactide (Synacthen®) test in non-classic congenital adrenal hyperplasia: an exception to the rule?Athanasia Stoupa, Laura González-Briceño, Graziella Pinto, et al.
Pediatric Diabetes|October 18, 2016
A description of clinician reported diagnosis of type 2 diabetes and other non-type 1 diabetes included in a large international multicentered pediatric diabetes registry (SWEET)Danièle Pacaud, Anke Schwandt, Carine de Beaufort, et al.
Frontiers in Endocrinology|October 26, 2023
Identifying patient-related predictors of permanent growth hormone deficiencyVeronica Mericq, German Iñiguez, Graziella Pinto, et al.
Nature Immunology|June 9, 2018
Author Correction: Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetesOphélie Rouxel, Jennifer DaSilva, Lucie Beaudoin, et al.
Nature Immunology|October 10, 2017
Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetesOphélie Rouxel, Jennifer Da Silva, Lucie Beaudoin, et al.
Diabetologia|July 2, 2020
Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I/II randomised, double-blind, placebo-controlled, dose-finding studyMichelle Rosenzwajg, Randa Salet, Roberta Lorenzon, et al.
Journal of Autoimmunity|June 20, 2016
A unique CD8(+) T lymphocyte signature in pediatric type 1 diabetesYamina Hamel, François-Xavier Mauvais, Hang-Phuong Pham, et al.
Diabetes Care|April 11, 2020
Long-term Metabolic and Socioeducational Outcomes of Transient Neonatal Diabetes: A Longitudinal and Cross-sectional StudyFleur Le Bourgeois, Jacques Beltrand, Baz Baz, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
European Journal of Endocrinology|March 19, 2010
Resistance to leptin-replacement therapy in Berardinelli-Seip congenital lipodystrophy: an immunological originJacques Beltrand, Najiba Lahlou, Tifenn Le Charpentier, et al.
Hormone Research in Paediatrics|January 13, 2017
Efficacy and Safety of Continuous Subcutaneous Infusion of Recombinant Human Gonadotropins for Congenital Micropenis during Early Infancy
Athanasia Stoupa, Dinane Samara-Boustani, Isabelle Flechtner, et al.
Hormone Research in Paediatrics|February 14, 2015
Inadequate cortisol response to the tetracosactide (Synacthen®) test in non-classic congenital adrenal hyperplasia: an exception to the rule?Athanasia Stoupa, Laura González-Briceño, Graziella Pinto, et al.
Pediatric Diabetes|October 18, 2016
A description of clinician reported diagnosis of type 2 diabetes and other non-type 1 diabetes included in a large international multicentered pediatric diabetes registry (SWEET)Danièle Pacaud, Anke Schwandt, Carine de Beaufort, et al.
Frontiers in Endocrinology|October 26, 2023
Identifying patient-related predictors of permanent growth hormone deficiencyVeronica Mericq, German Iñiguez, Graziella Pinto, et al.
Nature Immunology|June 9, 2018
Author Correction: Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetesOphélie Rouxel, Jennifer DaSilva, Lucie Beaudoin, et al.
Nature Immunology|October 10, 2017
Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetesOphélie Rouxel, Jennifer Da Silva, Lucie Beaudoin, et al.
Diabetologia|July 2, 2020
Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I/II randomised, double-blind, placebo-controlled, dose-finding studyMichelle Rosenzwajg, Randa Salet, Roberta Lorenzon, et al.
Journal of Autoimmunity|June 20, 2016
A unique CD8(+) T lymphocyte signature in pediatric type 1 diabetesYamina Hamel, François-Xavier Mauvais, Hang-Phuong Pham, et al.
Diabetes Care|April 11, 2020
Long-term Metabolic and Socioeducational Outcomes of Transient Neonatal Diabetes: A Longitudinal and Cross-sectional StudyFleur Le Bourgeois, Jacques Beltrand, Baz Baz, et al.
Pageof 9